EV/EBITDA
-55.68
+0.86+1.52%
Mon, 06 Jan 2025 22:14:34 GMT
Summary:
Kiniksa Pharmaceuticals EV/EBITDA is currently -55.68, with a rise of +0.86 (+1.52%) during the most recent trading day. Over the past year, it has dropped by -3.39 (-6.48%). KNSA EV/EBITDA is now -168.91% below its all-time high of 80.80.KNSA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KNSA EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +1.5% |
| 1 m1 month | +7.3% |
| 3 m3 months | +19.1% |
| 6 m6 months | -10.4% |
| ytdytd | -1.3% |
| 1 y1 year | -6.5% |
| 5 y5 years | -1264.7% |
KNSA EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -51.18 | -8.8% | -60.09 | +7.3% |
| 3 m | 3 months | -51.18 | -8.8% | -80.18 | +30.6% |
| 6 m | 6 months | -50.45 | -10.4% | -80.18 | +30.6% |
| 1 y | 1 year | -37.11 | -50.0% | -80.18 | +30.6% |
| 3 y | 3 years | 80.80 | -168.9% | -80.18 | +30.6% |
| 5 y | 5 years | 80.80 | -168.9% | -80.18 | +30.6% |
| alltime | all time | 80.80 | -168.9% | -80.18 | +30.6% |
Kiniksa Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -55.68(+1.3%) |
| 2024 | -54.97(+10.2%) |
| 2023 | -49.89(-165.5%) |
| 2022 | 76.16(-1788.7%) |
| Date | Value |
|---|---|
| 2021 | -4.51(-36.4%) |
| 2020 | -7.09(+111.0%) |
| 2019 | -3.36(-72.5%) |
| 2018 | -12.22 |
FAQ
- What is Kiniksa Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Kiniksa Pharmaceuticals?
- What is KNSA EV/EBITDA year-to-date change?
- What is Kiniksa Pharmaceuticals EV/EBITDA year-on-year change?
What is Kiniksa Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of KNSA is -55.68
What is the all time high EV/EBITDA for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high EV/EBITDA is 80.80
What is KNSA EV/EBITDA year-to-date change?
Kiniksa Pharmaceuticals EV/EBITDA has changed by -0.71 (-1.29%) since the beginning of the year
What is Kiniksa Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, KNSA EV/EBITDA has changed by -3.39 (-6.48%)